Bayer HealthCare is facing a conjoined Essure lawsuit from over a dozen women and or loved ones of Essure patients, alleging serious damage from Essure adverse effects.

Each of the claimants alleges serious Essure adverse effects, ranging from severe discomfort to the need for revision surgery. In addition to the patients themselves, some of the loved ones of Essure patients are also joining the suit citing damage permanently affecting their relationships.

Each of the women alleges the Essure adverse effects worsened their overall medical situation, and that they were not given any previous warnings against potential complications.

Overview of Essure Adverse Effects

These women had opted for the Essure birth control device for its longevity and convenience. They allege they were given no reason to be wary of potential complications stemming from design defects.

The Essure adverse effects mentioned by these women range in severity, with some cases being severe enough to warrant device removal. Some of the woman involves in the Essure lawsuit include, but certainly not limited to:

• Arizona plaintiff Madlyne B. had the Essure birth control device implanted in May 2007. She says she suffered no initial complications during implantation. However Madlyne soon began experiencing a number of Essure adverse effects including severe menstrual pain, irregular and prolonged menstruation, heavy and abnormal bleeding, abdominal pain, and hormonal fluctuations. Madlyne was eventually forced to undergo a hysterectomy to remove the Essure device on April 21, 2017.
• California plaintiff Ema H. had the Essure birth control device implanted in August 2014 and did not suffered any intial complications after implantation. However, not long after the Essure device was implanted, Ema reportedly suffered Essure adverse effects including severe menstrual pain, irregular and prolonged menstruation, heavy and abnormal bleeding, severe abdominal pain, cramping, severe migraines, bloating, pain during intercourse, hormonal fluctuations, and severe anemia. She eventually underwent a hysterectomy to remove the Essure device on Sept. 15, 2017.
• California plaintiff Dawn C. had the Essure birth control device implanted in November 2007, and did not suffer any initial complications after implantation. However, not long after the device was implanted, Dawn reportedly began suffering Essure adverse effects including unusual bleeding, cramping, prolonged menstruation, severe abdominal pain, hormonal fluctuations, ovarian cysts, device migration, and organ perforation. Dawn had to undergo hysterectomy to remove the Essure device in March 2017.

Each of the women mentioned above in the Essure lawsuit were provided an Essure brochure from Bayer HealthCare. The plaintiffs claim this brochure advertised the device’s benefits but did not sufficiently describe the potential side effects.

The Essure birth control device consists of two metal coils that are directly implanted inside the patient’s fallopian tubes, which triggers tissue growth around the coils. This ultimately blocks sperm to egg fertilization. The Essure birth control device is marketed to be a quick and hassle free contraceptive method that will provide the needed contraceptive effects for a long period of time.

However, consumer advocates have stated the Essure adverse effects are unreasonably dangerous, and that the device never should have been released onto the market. Since the device’s removal in 2002, the FDA has recovered over 4,500 Essure injury reports.

This Essure Lawsuit is Case No. 2:17-cv-03968-JS, in the U.S. District Court for the Eastern District of Pennsylvania.